510(k) Report

510(k) · Cleared

Cleared

Durette Ocular Implant

K123764510(k) TraditionalCleared Jan 31, 201355-day reviewClass II21 CFR 886.3320

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Oculo-Plastik, Inc. · HPZ Implant, Eye Sphere

Cleared on Jan 31, 2013 as substantially equivalent to K073293 (Oculo Plastik, Inc., 2008) after a 55-day review. Its family tree reaches back 1 generation to 2008.

Decided
Jan 31, 2013
Review
55 days
Class
Class II
Product code
HPZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K073293 (2008). No later device cites it as a predicate yet.

K073293 · Durette Implant · Oculo Plastik, Inc. · 200820062008201020122014
K073293 · Durette Implant · Oculo Plastik, Inc. · 20080
  1. Root · 1 generation backK073293 Durette ImplantOculo Plastik, Inc. · 2008
  2. This deviceK123764 Durette Ocular ImplantOculo-Plastik, Inc. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K073293Durette ImplantOculo Plastik, Inc.2008—
0 (this device)K123764Durette Ocular ImplantOculo-Plastik, Inc.2013—
FIG. 1 — Lineage of K123764, 2008–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HPZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HPZ device

  1. #1 K212741 Ezyporscore 3.6 · 1 generation · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K073293Durette Implant
Summary page 1
…sdesrosiers(@oculonlastik.com' To the reviewer: This is a submission for a 510O(k) for the Durette Implant, which were previously cleared by FDA in 2008 (K073293). The basis for this submission is change of welding process, packaging, and labeling. The predicate device was welded using a li…
Oculo Plastik, Inc.2008—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All HPZ devices

HPZ Implant, Eye Sphere: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · HPZ

1in 2022

2007: 22008: 12009: 22011: 22013: 12022: 1
2007high 2 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HPZ

Too few HPZ 510(k)s in any year since 2007 to give a median.

Recalls per year · HPZ

1in 2012

2010: 12012: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HPZ

6in 2011

2007: 52008: 72009: 52010: 32011: 6
2007high 7 (2008) · low 0 (2012)2025

MAUDE reports naming product code HPZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—05
20081—07
20092—05
20100—13
20112—06
20120—10
20131—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Durette ocular acrylic (PMMA) implants in 4 models are permanent implants that occupy the eye cavity when it becomes necessary to surgically remove the eye (enucleation), the contents of the eye sac (evisceration), or space left after the removal of another ocular implant (used as a secondary implant). It is used to replace volume and to impart motion and stability to the eventual ocular prosthesis.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123764: Durette Ocular Implant.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K123764

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026